Therapeutic Immunosuppression and its Risks

被引：0
|
作者：
Roecken, M. [1 ]
机构：
[1] Univ Klinikum Tubingen, Univ Hautklin, Tubingen, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：29 / 29
页数：1
相关论文
共 50 条
  • [41] Merkel cell carcinoma arising after therapeutic immunosuppression
    Gooptu, C
    Woollons, A
    Ross, J
    Price, M
    Wojnarowska, F
    Morris, PJ
    Wall, S
    Bunker, CB
    BRITISH JOURNAL OF DERMATOLOGY, 1997, 137 (04) : 637 - 641
  • [42] THERAPEUTIC STRATEGIES IN IMMUNOSUPPRESSION AFTER RENAL-TRANSPLANTATION
    MORRIS, PJ
    JOURNAL OF PEDIATRICS, 1987, 111 (06): : 1004 - 1007
  • [43] Reduction of immunosuppression for transplant-associated skin cancer: thresholds and risks
    Otley, C. C.
    Griffin, M. D.
    Charlton, M. R.
    Edwards, B. S.
    Neuburg, M.
    Stasko, T.
    BRITISH JOURNAL OF DERMATOLOGY, 2007, 157 (06) : 1183 - 1188
  • [44] RISKS IN THERAPEUTIC PORTACAVAL AND SPLENORENAL SHUNTS
    MALT, RA
    SZCZERBAN, J
    MALT, RB
    ANNALS OF SURGERY, 1976, 184 (03) : 279 - 288
  • [45] Risks associated with the therapeutic use of fluoroquinolones
    Stahlmann, Ralf
    Lode, Hartmut M.
    EXPERT OPINION ON DRUG SAFETY, 2013, 12 (04) : 497 - 505
  • [46] The utility and risks of therapeutic nanotechnology in the retina
    Scheive, Melanie
    Yazdani, Saeed
    Hajrasoutiha, Amir R.
    THERAPEUTIC ADVANCES IN OPHTHALMOLOGY, 2021, 13
  • [47] Cannabinoids and Schizophrenia: Risks and Therapeutic Potential
    Manseau, Marc W.
    Goff, Donald C.
    NEUROTHERAPEUTICS, 2015, 12 (04) : 816 - 824
  • [48] Risks of therapeutic versus prophylactic neurectomies
    Feng, Xiaoxi
    Fadaee, Negin
    Huynh, Desmond
    Capati, Isabel
    Towfigh, Shirin
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2022, 36 (09): : 6809 - 6814
  • [49] THERAPEUTIC RISKS ASSOCIATED WITH PHARMACEUTICAL ALTERNATIVES
    DAY, RL
    NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (13): : 834 - 834
  • [50] Cannabinoids and Schizophrenia: Risks and Therapeutic Potential
    Marc W. Manseau
    Donald C. Goff
    Neurotherapeutics, 2015, 12 : 816 - 824
12345